HIPPO PATHWAY DEFICIENCY REVERSES SYSTOLIC HEART FAILURE POST-INFARCTION

• 收藏
• 分享

专利权人:

Baylor College of Medicine

发明人:

James F. Martin,John Leach

申请号：

US16644435

公开号：

US20200206327A1

申请日:

2018.09.06

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Embodiments of the disclosure include methods and compositions related to treating or reducing the severity or delaying the onset of one or more cardiac conditions in a mammal In particular embodiments, the compositions concern Park2 and its use for a cardiac medical condition. In specific cases, effective amounts of Park2 polynucleotide(s) and/or Park2 polypeptide(s) are provided to an individual in need thereof, including for heart failure, for example. The administration may be locally to the heart, for example.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/